Sam Chun Dang Pharm Co Ltd (000250) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Sam Chun Dang Pharm Co Ltd (SCD) is a manufacturer of prescription medicines. The company offers products in the therapeutic areas of ophthalmology, cardiovasculars, endocrinology, gastrointestines, antibacterials, anti-fungals, antivirals, respiratory, antiinflammatories, antihistamines, musculoskeletals, and vitamines. Its ophthalmic drugs provides dry eye therapies, antibiotic eye drops, glaucoma therapeutics, shandong and snow cycloplegic, diabetic retinopathy, anti-bacterial and anti-inflammatory complexes, anti-inflammatory eye drops, allergic conjunctivitis therapeutics, and cataract therapeutics, among others. SCD offers its products in the dosage forms of capsules, tablet, injection and spray. The company conducts research activities for developing modified drugs for incurable diseases such as diabetes and hyperlipidemia. It also carries out formulation and ocular permeation research. SCD is headquartered in Seoul, South Korea.

Sam Chun Dang Pharm Co Ltd (000250) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Glenmark Pharma Enters into Agreement with Sam Chun Dang Pharm 11
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 12
Taiwan Liposome Enters into Agreement with Sam Chun Dang Pharm 13
Taiwan Liposome Enters Into Distribution Agreement With Sam Chun Dang Pharm For AmBiL 14
Debt Offering 15
Sam Chun Dang Pharm Completes Public Offering Of Bonds For US$7 Million 15
Acquisition 16
Sam Chun Dang Pharm Acquires 61.27% stake In DHP Korea For US$13 Million 16
Sam Chun Dang Pharm Co Ltd - Key Competitors 17
Sam Chun Dang Pharm Co Ltd - Key Employees 18
Sam Chun Dang Pharm Co Ltd - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables

List of Tables
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sam Chun Dang Pharm Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Glenmark Pharma Enters into Agreement with Sam Chun Dang Pharm 11
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 12
Taiwan Liposome Enters into Agreement with Sam Chun Dang Pharm 13
Taiwan Liposome Enters Into Distribution Agreement With Sam Chun Dang Pharm For AmBiL 14
Sam Chun Dang Pharm Completes Public Offering Of Bonds For US$7 Million 15
Sam Chun Dang Pharm Acquires 61.27% stake In DHP Korea For US$13 Million 16
Sam Chun Dang Pharm Co Ltd, Key Competitors 17
Sam Chun Dang Pharm Co Ltd, Key Employees 18
Sam Chun Dang Pharm Co Ltd, Other Locations 19

List Of Figures

List of Figures
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Samsung: Performance, Capabilities, Goals and Strategies in the Global Aerospace and Defense Market

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization

USD 950 View Report

Sampo plc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Sampo plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Sampo plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Sam Chun Dang Pharm Co, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Sam Chun Dang Pharm Co, Ltd Company Profile is a detailed strategic and analytical report on Sam Chun Dang Pharm Co, Ltd. The 2018 version of the report offers detailed

USD 200 View Report

Sam Chun Dang Pharm Co Ltd (000250) - Financial and Strategic SWOT Analysis Review

Sam Chun Dang Pharm Co Ltd (SCD) is a manufacturer of prescription medicines. The company offers products in the therapeutic areas of ophthalmology, cardiovasculars, endocrinology, gastrointestines, antibacterials, anti-fungals, antivirals, respiratory,

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available